The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806.
Gan HK, Walker F, Burgess AW, Rigopoulos A, Scott AM, Johns TG.
Gan HK, et al. Among authors: walker f.
J Biol Chem. 2007 Feb 2;282(5):2840-50. doi: 10.1074/jbc.M605136200. Epub 2006 Nov 8.
J Biol Chem. 2007.
PMID: 17092939
Free article.
We have shown that AG1478, a tyrosine kinase inhibitor of the EGFR, synergistically inhibits the growth of tumors overexpressing EGFR when used in combination with mAb 806 but the mechanism for this was not elucidated (Johns, T. G., Luwor, R. B., Murone, C., Walker, F …
We have shown that AG1478, a tyrosine kinase inhibitor of the EGFR, synergistically inhibits the growth of tumors overexpressing EGFR when u …